Amedisys, Inc. (AMED)
| Market Cap | 2.77B |
| Revenue (ttm) | 2.32B |
| Net Income (ttm) | 82.93M |
| Shares Out | 32.75M |
| EPS (ttm) | 2.52 |
| PE Ratio | 33.53 |
| Forward PE | 17.75 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,138,955 |
| Open | 84.02 |
| Previous Close | 83.78 |
| Day's Range | 82.17 - 84.87 |
| 52-Week Range | 82.17 - 98.95 |
| Beta | 0.73 |
| Analysts | Hold |
| Price Target | 100.67 (+19.18%) |
| Earnings Date | Feb 19, 2025 |
About AMED
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and ai... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 5 analysts, the average rating for AMED stock is "Hold." The 12-month stock price forecast is $100.67, which is an increase of 19.18% from the latest price.
News
US sues to block UnitedHealth's $3.3 bln purchase of Amedisys
The Justice Department and three U.S. states filed a lawsuit on Tuesday to block UnitedHealth Group's $3.3 billion purchase of Amedisys Inc over concern the deal would harm competition in the market f...
US Justice Department preps suit over UnitedHealth-Amedisys deal, Bloomberg News reports
The U.S. Justice Department is moving to block UnitedHealth Group's $3.3 billion purchase of Amedisys Inc. over concerns the deal would harm competition in the market for home health services, Bloombe...
Amedisys Reports Third Quarter 2024 Financial Results
BATON ROUGE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2024.
Amedisys has earned the 2023 SHPBest™ Patient Satisfaction Awards
BATON ROUGE, La., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, has 92 home health and hospice care cen...
Contessa Selected by Centers for Medicare & Medicaid Services to Test Medicare Dementia Care Model
Guiding an Improved Dementia Experience (GUIDE) Model Aims to Increase Care Coordination, Support for Caregivers Guiding an Improved Dementia Experience (GUIDE) Model Aims to Increase Care Coordinatio...
Amedisys Reports Second Quarter 2024 Financial Results
BATON ROUGE, La., July 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2024.
Amedisys Reports First Quarter 2024 Financial Results
BATON ROUGE, La., April 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2024.
Oregon's health authority reviewing UnitedHealth's acquisition of Amedisys
Amedisys said on Tuesday Oregon's health authority has started a review of UnitedHealth Group's $3.3 billion acquisition of the home health and hospice caregiver.
Amedisys Reports Fourth Quarter and Year-End 2023 Financial Results
BATON ROUGE, La., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2023.
Amedisys Offers Molecular Testing for Rapid and Accurate Infection Diagnosis
BATON ROUGE, La., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, is now offering advanced molecular testi...
Amedisys, Inc.: Why Stock Is A Hold Pending Agency Review
Amedisys, Inc. is set to be acquired by UnitedHealth Group in a $3.29 billion merger agreement. Some US legislators have called for further scrutiny of the merger, citing concerns of increased market ...
Amedisys Reports Third Quarter 2023 Financial Results
BATON ROUGE, La., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2023.
Amedisys Celebrates National Quality Week
Held October 15-21, this Observance Shines a Light on Our Commitment to Quality Care Held October 15-21, this Observance Shines a Light on Our Commitment to Quality Care
Amedisys Recognizes Suicide Prevention Awareness Month and Promotes the 988 Suicide & Crisis Lifeline
BATON ROUGE, La., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, is proud to recognize September as Suici...
Amedisys Reports Second Quarter 2023 Financial Results
BATON ROUGE, La., July 26, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2023.
UnitedHealth's Amedisys Deal Come as Home Health and Data Cement Care Ecosystems
In healthcare, the latest acquisition brings to mind that old Fred Astaire song lyric: “Won't you change partners and dance with me?” On Monday, as had been reported here, Amedisys, the home health an...
UnitedHealth Buys Amedisys for $3.3 Billion
UnitedHealth Group outbid Option Care's offer to buy home healthcare provider Amedisys.
Amedisys Agrees to UnitedHealth Takeover, Scraps Option Care Health Merger
The unsolicited offer from UnitedHealth outbid a $2.8 billion deal.
Amedisys Agrees to $3.3 Billion UnitedHealth Merger
Home health company Amedisys has agreed to a $3.3 billion merger with UnitedHealth Group. The deal calls for the acquisition of Amedisys' outstanding common stock in an all-cash transaction for $101 p...
UnitedHealth Agrees All-Cash Deal to Buy Amedisys
The move for the healthcare-service provider is worth $101 a share.
Amedisys agrees to UnitedHealth buyout offer, scraps Option Care deal
Amedisys Inc on Monday agreed to acquired by UnitedHealth Group for $101 per share in cash, and terminated an all-stock deal to be bought by Option Care Health Inc.
Amedisys agrees to merge with UnitedHealth, and terminates deal with Option Care Health
Amedisys Inc. AMED, -0.15% disclosed Monday that it has agreed to merge with UnitedHealth Group Inc. UNH, -0.43%, and terminated its merger with Option Care Health Inc. OPCH, +1.47% agreed on in early...
Amedisys and Optum to Combine, Advancing Value-Based Care for Patients
BATON ROUGE, La., June 26, 2023 (GLOBE NEWSWIRE) -- Amedisys (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care, and Optum, a diversified health services company, have agr...
Amedisys: Even Without A Bidding War, The Company Appears Undervalued
Amedisys is a leading healthcare services company dedicated to providing clinically excellent care and support at home. Currently reporting FCF generation and proposing workforce optimization, clinica...
Optum Bid for Amedisys Shows Ongoing Reinvention of the Private Healthcare Ecosystem
The growing yet fragmented home health space is moving toward a more consolidated and centralized footing one deal at a time as major players continue snapping up smaller ones, reinventing home health...